Supply and procurement of immunisation products

in page functions

Gavi’s market shaping activities are guided by a supply and procurement strategy.

Pfizer - empty vials on belt

Credit: Pfizer/2016.

The supply and procurement strategy guides our work towards achieving our fourth strategic goal, to shape markets for vaccines and other immunisation products.

Gavi’s first strategy for vaccine supply and procurement ran from 2011 until 2015. This strategy was focused on securing a sufficient and uninterrupted supply of vaccines, minimising vaccine costs, and ensuring appropriate and quality products. The delivery of timely, transparent and accurate market information to all partners underpinned these objectives.

Thanks to strong collaboration with partners and manufacturers, we were able to achieve all our market shaping goals for the 2011–2015 strategic period.


Despite good progress, challenges remain. Not only has the vaccine market landscape evolved significantly since 2011, but Gavi’s vaccine portfolio has doubled from 6 to 13 vaccines.

These developments, coupled with our new strategy’s stronger focus on improving coverage and equity, have guided the development of a new supply and procurement strategy for the 2016–2020 period.

Given the importance of functioning cold chain equipment to improve immunisation coverage and equity, our new supply and procurement strategy extends beyond vaccines to include such products. New vaccine products and presentations are now offered according to our product portfolio management principles.

Our market shaping efforts benefit all the countries we support. In addition, fully-self-financing countries can choose to participate in UNICEF tenders for up to five years after our support stops.


The supply and procurement strategy has three priorities:

  1. delivering on healthy markets;
  2. taking a long-term view of markets; and
  3. driving innovation to better meet country needs.

Every 2 minutes

One woman dies from cervical cancer every two minutes – or 266,000 a year – over 80% in developing countries. If current trends hold, and without changes in prevention and control, cervical cancer deaths could eventually outpace maternal deaths. HPV vaccines can prevent up to 90% of all cervical cancer cases.


More facts...

close icon

modal window here